ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 104 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $124,000 | -96.1% | 23,263 | -90.7% | 0.00% | -100.0% |
| Q3 2016 | $3,200,000 | +71.2% | 250,000 | +66.7% | 0.01% | +80.0% |
| Q2 2016 | $1,869,000 | -72.9% | 150,000 | -66.7% | 0.01% | -70.6% |
| Q2 2015 | $6,903,000 | -46.1% | 450,000 | -40.0% | 0.02% | -45.2% |
| Q1 2015 | $12,803,000 | -7.0% | 750,000 | -16.7% | 0.03% | -8.8% |
| Q4 2014 | $13,761,000 | +343.3% | 900,000 | +207.3% | 0.03% | +325.0% |
| Q3 2014 | $3,104,000 | -30.3% | 292,837 | 0.0% | 0.01% | -33.3% |
| Q2 2014 | $4,454,000 | +18.2% | 292,837 | 0.0% | 0.01% | +20.0% |
| Q1 2014 | $3,769,000 | -26.2% | 292,837 | 0.0% | 0.01% | -28.6% |
| Q4 2013 | $5,107,000 | -46.6% | 292,837 | -50.6% | 0.01% | -50.0% |
| Q3 2013 | $9,568,000 | -12.6% | 592,837 | -28.1% | 0.03% | -17.6% |
| Q2 2013 | $10,951,000 | -2.1% | 824,655 | +19.0% | 0.03% | -8.1% |
| Q1 2013 | $11,189,000 | – | 692,837 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,121,447 | $2,142,000 | 1.45% |
| Essex Woodlands Management, Inc. | 1,257,468 | $6,684,000 | 1.39% |
| Camber Capital Management LP | 9,300,000 | $17,763,000 | 0.76% |
| PFM Health Sciences, LP | 7,408,585 | $14,150,000 | 0.21% |
| NEA Management Company, LLC | 2,490,204 | $4,756,000 | 0.20% |
| ArrowMark Colorado Holdings LLC | 10,276,145 | $19,627,000 | 0.16% |
| Brown Capital Management | 8,977,308 | $17,147,000 | 0.16% |
| Partner Investment Management, L.P. | 79,765 | $152,000 | 0.12% |
| ALTRINSIC GLOBAL ADVISORS LLC | 1,135,000 | $2,168,000 | 0.10% |
| Lombard Odier Asset Management (USA) Corp | 700,000 | $1,337,000 | 0.10% |